top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
(ISC)2 SSCP systems security certified practitioner : official study guide / / Mike Wills
(ISC)2 SSCP systems security certified practitioner : official study guide / / Mike Wills
Autore Wills Mike
Pubbl/distr/stampa Indianapolis, Indiana : , : John Wiley & Sons, Incorporated, , [2019]
Descrizione fisica 1 online resource (691 pages)
Disciplina 005.8
Soggetto topico Computer networks - Security measures
Electronic data processing personnel - Certification
ISBN 1-119-54295-2
1-119-54292-8
1-119-54792-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910555045503321
Wills Mike  
Indianapolis, Indiana : , : John Wiley & Sons, Incorporated, , [2019]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
(ISC)2 SSCP systems security certified practitioner : official study guide / / Mike Wills
(ISC)2 SSCP systems security certified practitioner : official study guide / / Mike Wills
Autore Wills Mike
Pubbl/distr/stampa Indianapolis, Indiana : , : John Wiley & Sons, Incorporated, , [2019]
Descrizione fisica 1 online resource (691 pages)
Disciplina 005.8
Soggetto topico Computer networks - Security measures
Electronic data processing personnel - Certification
ISBN 1-119-54295-2
1-119-54292-8
1-119-54792-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910829828903321
Wills Mike  
Indianapolis, Indiana : , : John Wiley & Sons, Incorporated, , [2019]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
100 Years of Spanish Cinema
100 Years of Spanish Cinema
Autore Pavlović Tatjana
Edizione [1st ed.]
Pubbl/distr/stampa Hoboken : , : John Wiley & Sons, Incorporated, , 2008
Descrizione fisica 1 online resource (296 pages)
Disciplina 791.430946
Altri autori (Persone) AlvarezInmaculada
Blanco-CanoRosana
GrisalesAnitra
OsorioAlejandra
SánchezAlejandra
Soggetto topico Motion pictures -- Spain -- History
Soggetto genere / forma Electronic books.
ISBN 9781444304800
9781405184199
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Figures -- About the Authors -- Acknowledgments -- Preface -- 1 Silent Cinema and its Pioneers (1906-1930) -- 1 El ciego de aldea (Ángel García Cardona, 1906) -- 2 Amor que mata (Fructuós Gelabert, 1909) -- 3 Don Pedro el Cruel (Ricardo Baños, Albert Marro, 1911) -- 4 La aldea maldita (Florián Rey, 1930) -- 2 Surrealism (1924-1930) and the Advent of Sound (the Second Republic: 1931-1936) -- 1 Un chien andalou (Luis Buñuel, 1929) -- 2 Tierra sin pan (Luis Buñuel, 1933) -- 3 Spanish Civil War (1936-1939) -- 1 Suspiros de España (Benito Perojo, 1938) -- 2 Canciones para después de una guerra (Basilio Martín Patino, 1971) -- 4 The Autarky: Papier-Mâché Cinema (1939-1950) -- 1 Raza (José Luis Sáenz de Heredia, 1941) -- 2 Locura de amor (Juan de Orduña, 1948) -- 5 Neorealism: Status Quo and Dissent (1951-1961) -- 1 El cochecito (Marco Ferreri, 1960) -- 2 Viridiana (Luis Buñuel, 1961) -- 6 The "Liberal" Dictatorship and its Agony (1962-1975) -- 1 El verdugo (Luis García Berlanga, 1963) -- 2 El jardín de las delicias (Carlos Saura, 1970) -- 7 Cinema of the Transition: The Period of Disenchantment (1975-1979) -- 1 El desencanto (Jaime Chávarri, 1976) -- 2 El crimen de Cuenca (Pilar Miró, 1979) -- 8 Post-Franco Spain: The Pedro Almodóvar Phenomenon (1980-1991) -- 1 Pepi, Luci, Bom y otras chicas del montón (Pedro Almodóvar, 1980) -- 2 ¿Qué he hecho yo para merecer esto! (Pedro Almodóvar, 1984) -- 9 Contemporary Trends (1992 to the Present) -- 1 Vacas (Julio Medem, 1992) -- 2 Carícies (Ventura Pons, 1997) -- 3 Flores de otro mundo (Icíar Bollaín, 1999) -- 4 The Secret Life of Words (La vida secreta de las palabras) (Isabel Coixet, 2005) -- Glossary of Film Terms -- Historical Chronology -- Notes -- Bibliography -- Index.
Record Nr. UNINA-9910795816603321
Pavlović Tatjana  
Hoboken : , : John Wiley & Sons, Incorporated, , 2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
2D Nanomaterials : Synthesis, Properties, and Applications
2D Nanomaterials : Synthesis, Properties, and Applications
Autore Chakroborty Subhendu
Edizione [1st ed.]
Pubbl/distr/stampa John Wiley & Sons, Inc, 2024
Descrizione fisica 1 online resource (514 pages)
Altri autori (Persone) PalKaushik
Soggetto topico Nanostructured materials
Nanotechnology
ISBN 9781394167876
1394167873
9781394167883
1394167881
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title Page -- Copyright Page -- Contents -- Preface -- Part I: Synthesis of 2D Nanomaterials -- Chapter 1 Top-Down Strategies Synthesis of 2D Nanomaterial -- 1.1 Introduction -- 1.2 Top-Down Strategy Synthesis Method -- 1.2.1 Etching -- 1.2.2 Mechanical Milling -- 1.2.3 Sputtering -- 1.3 Laser Ablation -- 1.4 Characterizations and Toxicity of 2D Nanomaterials -- 1.5 Conclusions -- References -- Chapter 2 Bottom-Up Strategies for Synthesis of 2D Nanomaterial -- 2.1 Introduction -- 2.2 Types of 2D Nanomaterial -- 2.2.1 Graphene -- 2.2.2 MXenes -- 2.2.3 Black Phosphorus -- 2.2.4 Hexagonal Boron Nitride -- 2.2.5 Transition Metal Dichalcogenides -- 2.2.6 Graphitic Carbon Nitride -- 2.2.7 MOF and COF -- 2.3 Synthesis Strategies -- 2.3.1 Top-Down -- 2.3.1.1 Mechanical Milling -- 2.3.1.2 Electrospinning -- 2.3.1.3 Lithography -- 2.3.1.4 Sputtering -- 2.3.1.5 The Arc Discharge Method -- 2.3.1.6 Laser Ablation -- 2.3.2 Bottom-Up Method -- 2.3.2.1 Chemical Vapor Deposition -- 2.3.2.2 Sol-Gel Method -- 2.3.2.3 Solvothermal and Hydrothermal Methods -- 2.3.2.4 Soft and Hard Template and Reverse Micelle Methods -- 2.4 Bottom-Up Strategies for Synthesis of 2D Nanomaterial -- 2.5 Conclusion and Outlook -- References -- Chapter 3 Unveiling the Intricacies: Characterization Techniques for 2D Nanomaterials -- 3.1 Introduction -- 3.2 Characterization Techniques -- 3.2.1 XRD -- 3.2.2 SEM and TEM -- 3.2.3 Optical Microscope -- 3.2.4 AFM -- 3.2.5 XPS -- 3.2.6 RAMAN -- 3.3 Conclusion -- References -- Part II: Properties of 2D Nanomaterials -- Chapter 4 Crystal Structure, Magnetic and Mechanical Properties of 2D Nanomaterials -- 4.1 Introduction -- 4.2 Structure of 2D Materials -- 4.2.1 Graphene -- 4.2.2 Black Phosphorous -- 4.2.3 Transition Metal Dichalcogenide (TMDC) -- 4.3 Magnetic 2D Materials -- 4.4 Origin of Magnetization in 2D Materials.
4.5 Mechanical Properties of 2D Nanomaterials -- 4.6 Conclusion -- References -- Chapter 5 Electrical, Plasmonic, and Optical Properties of 2D Nanomaterials -- 5.1 Introduction -- 5.2 Overview of Two-Dimensional Nanomaterials (2D NMs) -- 5.3 Electrical Properties of 2D NMs -- 5.4 Optical Properties of 2D NMs -- 5.5 Plasmonic Properties of 2D NMs -- 5.6 Recent Applications of 2D NMs -- 5.6.1 2D NMs for BioMedical Application -- 5.6.2 2D NMs in the Field of Energy -- 5.6.3 2D NMs as Lubricant Additive -- 5.7 Challenges and Prospective -- 5.8 Conclusion -- Acknowledgments -- References -- Part III: Application of 2D Nanomaterials -- Chapter 6 Challenges Surrounding 2D Nanomaterials and Their Application to Photocatalytic Industrial Wastewater Treatment -- 6.1 Introduction -- 6.2 Photocatalysis for Industrial Wastewater Treatment -- 6.2.1 Principles of Photocatalysis -- 6.2.2 Photocatalytic Processes for Industrial Wastewater Treatment -- 6.2.3 Advantages and Limitations of Photocatalysis -- 6.3 2D Nanomaterials in Photocatalysis -- 6.3.1 Introduction to 2D Nanomaterials and Types Used in Photocatalysis -- 6.3.2 Key Properties and Characteristics of 2D Nanomaterials -- 6.3.3 Role of 2D Nanomaterials in Enhancing Photocatalytic Performance -- 6.4 Challenges in Utilizing 2D Nanomaterials for Photocatalytic Wastewater Treatment -- 6.4.1 Synthesis and Fabrication Challenges -- 6.4.2 Stability and Degradation Issues -- 6.4.3 Efficiency and Selectivity Considerations -- 6.4.4 Scalability and Cost-Effectiveness Challenges -- 6.5 Strategies to Overcome Challenges -- 6.5.1 Improvement of Synthesis and Fabrication Techniques -- 6.5.2 Enhancement of Stability and Durability -- 6.5.3 Optimization of Photocatalytic Performance -- 6.5.4 Economical and Scalable Production Methods -- 6.6 Case Studies and Applications.
6.6.1 Examples of Successful Applications of 2D Nanomaterials -- 6.6.2 Case Studies in Photocatalytic Industrial Wastewater Treatment -- 6.6.3 Lessons Learned and Future Prospects -- 6.7 Conclusion -- References -- Chapter 7 Application of 2D Nanomaterials for Energy Storage -- 7.1 Introduction -- 7.2 2D Nanomaterials for Application of Lithium Ion Batteries -- 7.3 Application of 2D Nanomaterials in Sodium Ion Batteries -- 7.4 Application of 2D Nanomaterials in Potassium Ion Batteries -- 7.5 Applications of 2D Nanomaterials in Supercapacitors -- Conclusions -- References -- Chapter 8 Innovation in Photoinduced Antibacterial 2D Nanomaterials -- 8.1 Introduction -- 8.2 Antibacterial Applications Based on Graphene-Induced Photostimulation -- 8.2.1 Nanomaterials for Antibacterial Transition-Metal Dichalcogenides/Oxides -- 8.2.2 Antibacterial Nanomaterials Based on Carbon Nitride -- 8.2.3 Antibacterial Nanomaterials Based on Black Phosphorus -- 8.2.4 Other 2D Antibacterial Nanomaterials -- 8.3 Antibacterial Mechanisms of Graphene-Based Family -- 8.3.1 Physical Contact Destruction -- 8.3.2 Oxidative Stress -- 8.3.3 Disruption of Bacterial Protein Interactions -- 8.3.4 Photo-Induced Mechanisms -- 8.4 Conclusion -- References -- Chapter 9 2D Nanomaterials for Drug Delivery System -- 9.1 Introduction -- 9.2 2D Material Biosynthesis -- 9.3 Encapsulation of 2D Materials -- 9.4 Hydrogel Encapsulation-2D Materials -- 9.5 2D Material Encapsulation-Liposomes -- 9.6 2D Supply Encapsulation-Micelle -- 9.7 Stimuli Responsive 2D Material SDDSs-Classification -- 9.8 Light-Sensitive SDDSs -- 9.9 Magnetic Field-Responsive SDDSs -- 9.10 Various Response Exhibits Diverse-Advantages/Disadvantages -- 9.11 2D Material SDDS Therapy-Cancer -- 9.12 Antibacterial -- 9.12.1 Central Nervous System -- 9.13 Orthopedic -- 9.14 Diabetes Mellitus.
9.15 2D Materials in Intelligent Drug Delivery System-Advantages -- 9.16 Disadvantages -- 9.17 Conclusion and Future Perspective -- Acknowledgements -- References -- Chapter 10 New Technology 2D Nanomaterials for Neural Tissue Engineering -- 10.1 Introduction -- 10.2 Regeneration of Tissue and Organ Repair in Nature -- 10.2.1 The 'Curious Case' of Lizard: A Nature's Classic -- 10.2.2 Regenerative Capabilities of Amphibians -- 10.2.3 Regeneration in Humans -- 10.3 Nanotechnology and Neural Tissue Engineering -- 10.3.1 Definition of Nanotechnology -- 10.3.2 Synthesis of Nanomaterials or Nanoparticles -- 10.4 2D Nanomaterials for Tissue Engineering Application -- 10.4.1 Graphene-Based Nanomaterials in Tissue Engineering -- 10.4.2 Black-Phosphorus (BP)-Based Nanosheets in Tissue Engineering -- 10.4.3 Application of 2D Nanoclay in Tissue Engineering -- 10.5 2D Nanomaterials and Peripheral Nerve Engineering -- 10.5.1 Peripheral Nerve -- 10.5.2 Damage and Regeneration in Peripheral Nerve -- 10.5.3 Key Features of Nanomaterials in Neural Tissue Engineering -- 10.5.4 Mechanism of 2D Nanomaterial-Based Neural Regeneration -- 10.5.4.1 Graphene -- 10.5.4.2 Graphene Oxide -- 10.5.4.3 Black Phosphorus (BP) -- 10.6 Application of 2D Nanomaterials in Spinal Cord Repair -- 10.7 2D Nanomaterials for Drug/Gene Delivery -- 10.8 Challenges and Prospects -- References -- Chapter 11 Theranostic Approach of 2D Nanomaterials in Breast Cancer -- 11.1 Introduction -- 11.2 Applications -- Conclusion -- Acknowledgments -- References -- Chapter 12 2D Nanomaterials for Photocatalytic Hydrogen Production -- 12.1 Introduction -- 12.2 Basics of Photocatalytic Hydrogen Production -- 12.3 2D Nanomaterials for Photocatalytic Hydrogen Production -- 12.3.1 Graphene-Based -- 12.3.2 Carbon Nitrides -- 12.3.3 Transition Metal Dichalcogenides -- 12.3.4 MXene.
12.4 Enhancing the Photocatalytic Performance -- 12.5 Conclusion and Outlook -- Acknowledgments -- References -- Chapter 13 Supercapacitor Based on 2D Nanomaterials and Their Hybrid -- 13.1 Introduction -- 13.2 Structure Design of 2D Nanomaterial-Based Supercapacitors -- 13.3 2D Nanomaterials for Supercapacitor Technology -- 13.3.a Transition Metal Oxides (TMOs) and Transition Metal Hydroxides (TMHs)-Based Supercapacitor -- 13.3.a.1 Transition Metal Oxides -- 13.3.a.2 Transition Metal Hydroxides -- 13.3.b Transition Metal Carbide/Carbonitride (MXene)-Based Supercapacitor -- 13.3.c Transition Metal Dichalcogenide (TMD)-Based Supercapacitor -- 13.3.d Black Phosphorous-Based Supercapacitor -- 13.4 Conclusions -- References -- Chapter 14 2D Nanomaterials Based for Electrocatalytic Application -- 14.1 Introduction -- 14.1.1 Introduction to 2D Nanomaterials and Their Unique Properties -- 14.1.2 Motivation for Utilizing 2D Nanomaterials in Electrocatalytic Applications -- 14.2 Types of 2D Nanomaterials -- 14.2.1 Graphene -- 14.2.2 Dichalcogenides (TMDs) -- 14.2.3 Brief Overview of Their Structures and Properties -- 14.3 Electrocatalytic Reactions Enabled by 2D Nanomaterials -- 14.3.1 Oxygen Reduction Reaction (ORR) -- 14.3.2 Hydrogen Evolution Reaction (HER) -- 14.3.3 Carbon Dioxide Reduction Reaction (CO2RR) -- 14.3.4 Synthesis and Characterization Techniques -- 14.3.4.1 Synthesis Methods for 2D Nanomaterials -- 14.3.4.2 Characterization Techniques for 2D Nanomaterials -- 14.3.4.3 Relationship Between Synthesis, Structure, and Electrocatalytic Performance -- 14.4 Challenges and Future Perspectives -- 14.4.1 Current Challenges in Utilizing 2D Nanomaterials for Electrocatalytic Applications -- 14.4.2 Potential Strategies to Overcome These Challenges -- 14.4.3 Future Directions and Emerging Trends in the Field -- 14.5 Conclusion -- References.
Chapter 15 Engineering 2D Nanomaterials for Biomedical Applications.
Record Nr. UNINA-9910877556903321
Chakroborty Subhendu  
John Wiley & Sons, Inc, 2024
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
3D Bioprinting from Lab to Industry
3D Bioprinting from Lab to Industry
Autore Saha Prosenjit
Edizione [1st ed.]
Pubbl/distr/stampa Newark : , : John Wiley & Sons, Incorporated, , 2024
Descrizione fisica 1 online resource (531 pages)
Altri autori (Persone) ThomasSabu
KimJinku
GhoshManojit
Soggetto topico Tissue engineering
Regenerative medicine
ISBN 9781119894407
1119894409
9781119894384
1119894387
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Foreword -- Chapter 1 Introduction of 3D Printing and Different Bioprinting Methods -- 1.1 Introduction of 3D Printing: Principles and Utility -- 1.2 Ink Preparation and Printability -- 1.3 Methods of Bioprinting in Fabrication and Tissue Engineering -- 1.3.1 Laser-Based Printing -- 1.3.1.1 Types of Laser Printing -- 1.3.2 Extrusion-Based Printing -- 1.3.3 Droplet Printing -- 1.3.4 Inkjet-Based Printing -- 1.3.5 Stereolithography 3D Printing -- 1.4 Scaffold Modeling and G Coding -- 1.4.1 Scanning Technology -- 1.4.2 CT Imaging -- 1.4.3 MRI Scanning -- 1.4.4 Preferred Accuracy Parameters for Scanning -- 1.4.5 Biomodeling Process for RP -- 1.5 Applications and Utility in Large-Scale Manufacturing -- 1.5.1 Bone -- 1.5.2 Cartilage -- 1.5.3 Skin -- 1.5.4 Vascular Grafts -- 1.5.5 Heart -- 1.5.6 Lungs -- 1.5.7 Liver -- 1.5.8 Kidney and Urethra -- 1.5.9 Brain and Spinal Cord -- 1.5.10 Cornea -- 1.5.11 Therapeutics -- 1.6 Complications and Troubleshooting -- 1.6.1 Laser-Based Printing -- 1.6.2 Inkjet-Based Printing -- 1.6.3 Extrusion-Based Printing -- 1.6.4 Droplet Printing -- 1.6.5 Stereolithography 3D Printing -- References -- Chapter 2 Cellular Requirements and Preparation for Bioprinting -- 2.1 Introduction -- 2.2 Types of Bioprinting -- 2.2.1 Inkjet-Assisted Printing -- 2.2.2 Extruder-Assisted Printing -- 2.2.3 Laser-Assisted Bioprinting -- 2.3 Features Required for Bioprinting with Cells -- 2.3.1 Sterility Parameters -- 2.3.2 Printing Speed and Pressure -- 2.3.3 pH and Osmotic Condition -- 2.3.4 Hydrogel Generation -- 2.3.4.1 Natural Polymers -- 2.3.4.2 Synthetic Polymers -- 2.3.5 Culture Duration and Conditions -- 2.3.6 Rheological Properties -- 2.4 Bioprinting Methodologies for Cell Expansion and Proliferation.
2.5 The Impact of Bioprinting Process Conditions on Phenotype Alterations -- 2.5.1 Bioprinting Techniques for Stem Cell Differentiation -- 2.5.1.1 Bioprinting Strategies for Cellular Environment Alterations -- 2.5.1.2 Bioprinting Strategies for Cell Behavior Modulation -- 2.5.1.3 Bioprinting Strategies for Genetic Modulationand Transcriptomics Variation -- 2.5.2 Bioprinting Techniques for Tumorigenic Differentiation -- 2.5.2.1 Bioprinting Strategies for Oncogenic Cell Growth -- 2.5.2.2 Bioprinting Strategies for the Development of Tumor Models -- 2.6 Discussion -- 2.7 Conclusion -- 2.8 Future Prospects -- References -- Chapter 3 3D Bioprinting: Materials for Bioprinting Bioinks Selection -- 3.1 Introduction -- 3.2 Bioprinting Materials -- 3.2.1 Biomaterials -- 3.2.2 Cells -- 3.2.3 Biomolecules or Additive Molecules -- 3.2.4 Hydrogels -- 3.3 Bioinks Selectivity Guide -- 3.3.1 Printability of Materials -- 3.3.2 Material Biocompatibility -- 3.3.3 Structural Properties -- 3.3.4 Materials Degradation -- 3.3.5 Biomimicry -- 3.4 Classification of Bioprinting Materials -- 3.4.1 According to Material Type -- 3.4.1.1 Polymers -- 3.4.1.2 Nanocomposites -- 3.4.1.3 Nanoparticles -- 3.4.2 According to Cell Dependence -- 3.4.2.1 Cell-basedBioinks -- 3.4.2.2 Cell-FreeBioinks (Biomaterial Inks) -- 3.5 3D Bioprinting Methods According to the Type of the Bioinks -- 3.5.1 Extrusion-Based 3D Bioprinting -- 3.5.2 Inkjet 3D Bioprinting -- 3.5.3 Stereolithography 3D Bioprinting -- 3.5.4 Laser-Based 3D Bioprinting -- 3.5.5 Bioplotting -- 3.6 Bioinks Selection According to Biomedical Application -- 3.7 Multicomponent Bioinks -- 3.8 Future Prospects -- References -- Chapter 4 Printed Scaffolds in Tissue Engineering -- 4.1 Introduction -- 4.2 Biomedical Application of 3D Printing -- 4.2.1 Implants and Scaffolds -- 4.2.2 Drug Delivery/Drug Modeling Application.
4.2.3 Applications of 3D Printed Scaffolds During COVID-19 -- 4.3 Tissue Engineering: Emerging Applications by 3D Printing -- 4.3.1 Cartilage Tissue Engineering by Printed Scaffolds -- 4.3.2 Liver Tissue Engineering by Printed Scaffolds -- 4.3.3 Nerve Tissue Engineering by Printed Scaffolds -- 4.3.4 Cardiac Tissue Engineering by Printed Scaffolds -- 4.4 Conclusions -- References -- Chapter 5 Printability and Shape Fidelity in Different Bioprinting Processes -- 5.1 Introduction -- 5.2 Fundamentals of Printability -- 5.3 Bioprinting Techniques and Printability -- 5.3.1 Extrusion-Based Bioprinting -- 5.3.2 Inkjet-Based Bioprinting -- 5.3.3 Stereolithography-Based Bioprinting (SL) -- 5.4 Shape Fidelity -- 5.4.1 Shape Fidelity in Planar Structures -- 5.4.2 Shape Fidelity in Multilayered Structures -- 5.4.3 Characterization Approaches -- 5.4.3.1 Rheological Characterization -- 5.4.3.2 Mechanical Characterization -- 5.4.3.3 Swelling Test -- 5.4.3.4 Viability Characterization -- 5.4.3.5 Bioprinting Procedure -- 5.5 Case Studies and Applications -- 5.6 Conclusion -- References -- Chapter 6 Advancements in Bioprinting for Medical Applications -- 6.1 Introduction -- 6.2 Bioprinting for Drug Development and Testing -- 6.2.1 Overview -- 6.2.2 3D Bioprinted Organoids -- 6.2.3 Organ-on-a-Chip/Microfluidic Systems -- 6.2.4 Bioprinted Models for Cancer Research -- 6.2.5 3D Bioprinting for Immunotherapy and Cell Therapy -- 6.3 Bioprinting in Tissue Engineering, Regenerative Medicine, and Organ Transplantation -- 6.3.1 Ocular Tissue Engineering -- 6.3.1.1 Retina -- 6.3.1.2 Cornea -- 6.3.2 Neural Tissue -- 6.3.3 Skin -- 6.3.3.1 Disease and Pharmaceutical Studies -- 6.3.3.2 Wound Healing -- 6.3.3.3 Reconstructive Surgery -- 6.3.4 Cartilage and Bone -- 6.3.4.1 Cartilage Printing Modalities -- 6.3.4.2 Cartilage Regeneration -- 6.3.5 Vascular Tissue.
6.3.6 Cardiac Tissue Engineering -- 6.3.7 Pancreas -- 6.3.7.1 Modulating Bioink Formulation to Enhance Tissue Viability -- 6.3.7.2 Controlling Other Printing Parameters to Enhance Tissue Viability -- 6.3.7.3 Using Printed Models to Study Pancreatic Cancer -- 6.3.8 Liver -- 6.3.8.1 Developing Suitable In Vitro Models -- 6.3.9 Lungs -- 6.3.9.1 Developing Suitable In Vitro Models -- 6.3.9.2 Application of 3D Construct -- 6.3.10 Renal/Kidney -- 6.3.10.1 Printing Parameters Affecting the Viability of Printed Model -- 6.3.10.2 Applications of 3D-PrintedModel -- 6.3.11 Composite Tissues -- 6.3.12 Other Tissues -- 6.4 Bioprinting in Tissue: Challenges, Barriers to Clinical Translation, and Future Directions -- 6.4.1 Introduction -- 6.4.1.1 Current Challenges in Organ Transplantation -- 6.4.1.2 Potential of Bioprinted Organs for Transplantation -- 6.4.1.3 Challenges and Limitations in Bioprinting Tissues and Organs -- 6.4.2 Insight on Barriers to Clinical Translation of Bioprinting Technology -- 6.4.3 Future Directions -- 6.5 Conclusions -- Acknowledgments -- References -- Chapter 7 4D-Printed, Smart, Multiresponsive Structures and Their Applications -- 7.1 Introduction -- 7.2 4D-Printing Technologies -- 7.3 Biomaterials for 4D Bioprinting -- 7.3.1 Water-Responsive Polymers -- 7.3.2 Temperature-Responsive Polymers (Hydrogels) -- 7.3.3 Electrical/Magnetic-Responsive Polymers -- 7.4 Biomedical Applications for 4D Bioprinting -- 7.4.1 Limitations of 3D Bioprinting -- 7.4.2 Biomedical Applications of 4D Printing -- 7.4.3 Scaffold Preparation -- 7.4.4 Drug Delivery -- 7.4.5 Sensors -- 7.4.6 Medical Devices -- 7.4.7 Tissue Engineering and Organ Regeneration -- 7.5 Future Perspectives -- References -- Chapter 8 Toxicity Aspects and Ethical Issues of Bioprinting -- 8.1 Introduction -- 8.2 Toxicity Issues in Bioprinting -- 8.2.1 Cell Harvesting and Culture.
8.2.2 Aseptic Techniques in Bioprinting -- 8.3 Ethical Issues in Bioprinting -- 8.3.1 Purpose -- 8.3.2 Cell Source -- 8.3.3 Data and Consent -- 8.3.4 Safety -- 8.3.5 Cost and Equity -- 8.3.6 Reproductive Organs -- 8.4 Issues in Clinical Trials -- 8.4.1 Personalized Treatment -- 8.4.2 Inability to Withdraw or Access Alternate Treatments -- 8.5 Legal Issues in Bioprinting -- 8.5.1 Intellectual Property Rights and Product Classification -- 8.5.2 Lack of Regulatory Guidelines -- 8.6 Conclusion -- References -- Chapter 9 Planning Bioprinting Project -- 9.1 Introduction -- 9.2 Background: Image Capturing and Solid Model Preparation of Virtual Anatomical Model for 3D Printing -- 9.2.1 Other Imaging Techniques -- 9.2.2 Digital Process for STL Generation -- 9.2.3 Blueprint Modeling -- 9.2.4 CAD-Based Systems Characteristics -- 9.2.5 Image-Based Systems -- 9.2.6 Freeform Systems -- 9.2.7 Designs Using Implicit Surfaces -- 9.2.8 Space-Filling Curves -- 9.2.9 Planning of Toolpath for Bioprinting -- 9.2.10 Cartesian Form Toolpath Planning -- 9.2.11 Parametric Form in Toolpath Planning -- 9.2.12 Bioprinting Methods -- 9.2.12.1 Extrusion Bioprinting -- 9.2.12.2 Inkjet Printing -- 9.2.12.3 Laser-AssistedPrinting -- 9.3 Conclusion -- References -- Chapter 10 Computational Engineering for 3D Bioprinting: Models, Methods, and Emerging Technologies -- 10.1 Introduction -- 10.2 Fundamentals of Numerical Methods in Bioprinting -- 10.2.1 Finite Element Analysis -- 10.2.2 Computational Fluid Dynamics -- 10.2.3 Agent-Based Modeling -- 10.2.4 Lattice Boltzmann Method -- 10.2.5 Molecular Dynamics -- 10.3 Application of Machine Learning for 3D Bioprinting -- 10.4 Summary -- References -- Chapter 11 Controlling Factors of Bioprinting -- 11.1 Introduction -- 11.2 Factors Influencing the Printability of Hydrogel Bioink -- 11.2.1 Extrudability -- 11.2.2 Filament Type.
11.2.3 Shape Fidelity.
Record Nr. UNINA-9910877612803321
Saha Prosenjit  
Newark : , : John Wiley & Sons, Incorporated, , 2024
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
3D Concrete Printing : State of the Art and Applications
3D Concrete Printing : State of the Art and Applications
Autore Perrot Arnaud
Edizione [1st ed.]
Pubbl/distr/stampa Newark : , : John Wiley & Sons, Incorporated, , 2025
Descrizione fisica 1 online resource (261 pages)
Disciplina 624.1834028
Altri autori (Persone) JacquetYohan
Collana ISTE Consignment Series
ISBN 9781394352074
1394352077
9781394352081
1394352085
9781394352067
1394352069
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910947809903321
Perrot Arnaud  
Newark : , : John Wiley & Sons, Incorporated, , 2025
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
3D Printing in Healthcare : Novel Applications
3D Printing in Healthcare : Novel Applications
Autore Malviya Rishabha
Edizione [1st ed.]
Pubbl/distr/stampa Newark : , : John Wiley & Sons, Incorporated, , 2024
Descrizione fisica 1 online resource (308 pages)
Altri autori (Persone) SharmaRishav
Soggetto topico Three-dimensional printing
Medical technology
ISBN 9781394234233
1394234236
9781394234219
139423421X
9781394234226
1394234228
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Series Page -- Title Page -- Copyright Page -- Contents -- Foreword -- Preface -- Chapter 1 Introduction to 3D Printing in Healthcare -- 1.1 Introduction -- 1.2 The Revolutionary Rise of 3D Printing Technology -- 1.3 3D Printing Revolution Engineering -- 1.4 3D Printer Types for Additive Manufacturing -- 1.5 3D Printing in the Healthcare Industry -- 1.6 Early-Phase Drug Development -- 1.7 Customized Drugs -- 1.8 Advanced Pharmacological Treatments -- 1.9 Community Medicine -- 1.10 Clinical Pharmacy Practice -- 1.11 3D Printing Process and Product Variable Optimization -- 1.12 Recent Trends in 3D Printing Regulation -- 1.13 Conclusion -- References -- Chapter 2 3D Printing in Medical Science -- 2.1 Introduction -- 2.2 Present Clinical Applications -- 2.3 3D-Printed Models in CHD -- 2.4 Cardiovascular Disease Models in 3D Printing -- 2.5 Tumor in 3D-Printed Models -- 2.6 3D-Printed Models in the Development of CT Scanning Procedures -- 2.7 Pharmaceutical 3D-Printing Technologies
Record Nr. UNINA-9910900181603321
Malviya Rishabha  
Newark : , : John Wiley & Sons, Incorporated, , 2024
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
3D Printing of Pharmaceutical and Drug Delivery Devices : Progress from Bench to Bedside
3D Printing of Pharmaceutical and Drug Delivery Devices : Progress from Bench to Bedside
Autore Lamprou Dimitrios A.
Edizione [First eddition.]
Pubbl/distr/stampa Newark : , : John Wiley & Sons, Incorporated, , 2024
Descrizione fisica 1 online resource (265 pages)
Disciplina 615.19
Altri autori (Persone) DouroumisDennis
QiSheng
Collana Advances in Pharmaceutical Technology Series
Soggetto topico Drug delivery systems
Pharmaceutical technology
ISBN 9781119836001
111983600X
9781119835981
1119835984
9781119835998
1119835992
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- 3D Printing of Pharmaceutical and Drug Delivery Devices -- Contents -- About the Editors -- List of Contributors -- Series Preface -- Preface -- 1 Materials for 3D Printing -- 1.1 Introduction -- 1.2 Material Processability Considerations for Pharmaceutical 3DP -- 1.2.1 Thermal Extrusion-Based 3D Printing -- 1.2.1.1 Thermal Considerations -- 1.2.1.2 Solubility Enhancement -- 1.2.1.3 Mechanical Considerations -- 1.2.2 Semi-Solid Extrusion 3DP -- 1.2.2.1 Rheological Considerations -- 1.2.2.2 Example Applications -- 1.2.3 Powder Bed Fusion 3D Printing -- 1.2.3.1 Powder Flowability Considerations -- 1.2.3.2 Powder Packing Density Considerations -- 1.2.3.3 Powder Energy Absorbance Considerations -- 1.2.4 Stereolithography 3D Printing -- 1.3 Classification of Common Materials Used in Pharmaceutical 3DP -- 1.3.1 Alcohol Derived Polymers -- 1.3.2 Eudragits -- 1.3.3 Other Polymers -- 1.3.4 Graft Polymers -- 1.3.5 Photocrosslinkable -- 1.3.6 Natural Materials -- 1.3.7 Lipid Materials -- 1.4 Conclusions and Future Perspectives -- References -- 2 The Use of Microstructure Design and 3D Printing for Tailored Drug Release -- 2.1 Introduction -- 2.2 3D-Printing Technologies -- 2.3 3D Design for Drug-Loaded Device -- 2.3.1 CAD Design-Based Design -- 2.3.2 Computational Software-Based Design -- 2.3.3 3D-Printing Parameter-Based Design -- 2.3.4 Polypills and Complex Designs -- 2.4 3D Designs Influence Drug Release -- 2.4.1 Controlling Drug Release -- 2.4.2 Modifying Drug Release -- 2.5 Challenges and Perspective -- References -- 3 3D Printing of Oral Solid Dosage Forms Using Selective Laser Sintering -- 3.1 Introduction -- 3.2 Operational Principles of Selective Laser Sintering -- 3.2.1 Manufacturing Challenges for SLS -- 3.2.2 Laser Selection and Scanning Speed -- 3.2.3 Powder Material Parameters -- 3.2.4 Powder Bed and Recoater Parameters.
3.3 3D-Printed Oral Dosages -- 3.4 Advantages of SLS -- 3.4.1 Printing Features -- 3.4.2 Control of Surface Properties -- 3.4.3 Printing of Complex Geometries -- 3.4.4 Using a Wide Range of Materials -- 3.4.5 Drug Loading and Dose Combinations -- 3.4.6 Personalised Dosage Forms -- 3.4.7 SLS Disadvantages -- 3.5 Conclusions -- References -- 4 3D Printing for Medical Device Applications -- 4.1 Introduction -- 4.2 3D Printers -- 4.2.1 SLA -- 4.2.2 FFF -- 4.2.3 Selective Laser Sintering (SLS) -- 4.3 Biomaterials for 3D-Printed Medical Devices -- 4.3.1 Bioresorbable Polymers -- 4.3.1.1 Synthetic Bioresorbable Polymers -- 4.3.1.2 Natural Bioresorbable Polymers -- 4.3.2 Non-Bioresorbable Polymers -- 4.3.3 Smart Polymers -- 4.3.4 Metal and Ceramic -- 4.4 3D-Printed Personalised Medical Devices -- 4.4.1 Vascular Repair Devices -- 4.4.2 Splints -- 4.4.3 Nerve Guidance Conduits -- 4.4.4 Tissue Engineering -- 4.4.5 3D Printing in Dentistry -- 4.4.6 3D-Printed Orthopaedic Devices -- 4.5 Regulatory -- 4.6 Future Perspectives -- References -- 5 3D Printed Implants for Long-Acting Drug Delivery -- 5.1 Introduction -- 5.2 Types of 3D-Printed Scaffolds -- 5.2.1 Implantable Scaffolds -- 5.2.1.1 Passive Implants -- 5.2.1.2 Active Implants -- 5.2.2 Injectable Scaffolds -- 5.2.3 Innovative 3D-Printed Scaffolds -- 5.3 Critical Parameters in Designing 3D-Printed Implantable Scaffolds -- 5.3.1 Structural Characteristics -- 5.3.1.1 Geometry of Implants -- 5.3.1.2 Porosity Properties and Pore Features -- 5.3.1.3 Surface Properties -- 5.3.2 Mechanical Properties -- 5.3.3 Biological and Physiological Parameters -- 5.3.3.1 Cellular Adhesion -- 5.3.3.2 Absorption and Degradation Rates -- 5.3.3.3 Biocompatibility Aspects -- 5.4 Critical Parameters in Selecting Materials for 3D-Printed Scaffolds -- 5.4.1 Materials Used in 3D-Printed Long-Acting Scaffolds -- 5.4.1.1 Natural Polymers.
5.4.1.2 Synthetic Polymers -- 5.4.1.3 Ceramics and Metals -- 5.4.1.4 Composites -- References -- 5.5 Manufacturing Techniques for Implantable Scaffolds -- 5.5.1 Hot-Melt Extrusion -- 5.5.2 Compression -- 5.5.3 Injection Moulding -- 5.5.4 Solvent Casting -- 5.5.5 3D Printing -- 5.5.6 Scale-Up in 3D-Printing Process for the Manufacturing of Scaffolds -- 5.6 Drug Release Mechanism of Long-Acting 3D-Printing Polymeric Implantable Systems -- 5.7 Outlining Regulatory Framework for 3D-Printed Implantable Scaffolds -- 5.7.1 Commercial Implantable Scaffolds -- 5.8 Conclusions -- References -- 6 Wound Dressings by 3D Printing -- 6.1 Wound Healing Process -- 6.1.1 Haemostasis/Coagulation -- 6.1.2 Inflammation -- 6.1.3 Proliferation -- 6.1.4 Re-epithelisation/Remodelling -- 6.1.5 Wound Classification -- 6.1.6 Wound Dressings -- 6.1.7 3D Printing -- 6.1.8 3D-Printed Dressings -- 6.2 Case Studies -- 6.3 Summary/Conclusions -- References -- 7 3D Printing of Hydrogels -- 7.1 Introduction -- 7.2 Applications of 3D-Printed Hydrogels -- 7.2.1 Tissue Engineering -- 7.2.2 Wound Healing -- 7.2.3 Drug Delivery -- 7.3 Types of Hydrogel Materials for 3D Printing -- 7.3.1 Natural Polymers -- 7.3.2 Synthetic Polymers -- 7.3.3 Natural-Synthetic Hybrid Polymers -- 7.3.4 Ionically Charged Polymers -- 7.3.5 Crosslinked Polymers -- 7.3.6 Method of Hydrogel Preparation -- 7.4 3D Printing Techniques for Hydrogels -- 7.4.1 Laser-Based 3D Printing -- 7.4.1.1 Stereolithography -- 7.4.1.2 Two-Photon Polymerisation -- 7.4.1.3 Laser-Induced Forward Transfer -- 7.4.2 Extrusion-Based Printing -- 7.4.3 Inkjet-Based Printing -- 7.5 Printability and Printing Parameters -- 7.5.1 Bioink Design -- 7.5.1.1 Materials Selection, Concentration and Viscosity -- 7.5.1.2 Rheological Properties -- 7.5.1.3 Shear-Thinning -- 7.5.1.4 Viscoelasticity and Yield Stress -- 7.5.1.5 Cell Encapsulation.
7.5.2 Crosslinking Techniques -- 7.5.2.1 Thermal Crosslinking -- 7.5.2.2 Physical Ionic Crosslinking -- 7.5.2.3 Chemical Crosslinking -- 7.5.2.4 Photocrosslinking -- 7.5.3 3D Printing Parameters -- 7.5.3.1 Temperature -- 7.5.3.2 Pressure -- 7.5.3.3 Speed -- 7.6 Clinical Translation -- 7.6.1 Regulatory Considerations -- 7.6.2 Manufacturing Considerations -- 7.6.3 Limitations and Future Direction -- 7.7 Conclusions -- References -- 8 Analytical Characterisation of 3D-Printed Medicines -- 8.1 Introduction -- 8.2 Preformulation -- 8.2.1 Thermal Analysis -- 8.2.2 X-Ray Powder Diffraction (XRPD) -- 8.2.3 Infrared Spectroscopy -- 8.2.4 Hot-Stage Microscopy (HSM) -- 8.2.5 Customizsd Sample Preparation for the Preformulation Protocol -- 8.3 In-Process Characterisations -- 8.3.1 Mechanical Analysis -- 8.3.2 Rheological Analysis -- 8.3.3 Drug Characterisation -- 8.4 Final Product -- 8.4.1 Morphological Analysis -- 8.4.2 X-Ray Computed Microtomography (XμCT) -- 8.4.3 Terahertz Pulsed Imaging (TPI) -- 8.4.4 Mercury Porosimetry -- 8.4.5 Helium Pycnometry -- 8.5 Conclusions -- References -- 9 Adoption of 3D Printing in Pharmaceutical Industry -- 9.1 Partnering and Growing -- 9.2 Regulatory Strategy -- 9.2.1 Product Development -- 9.2.2 Manufacturing -- 9.3 Business Model -- 9.3.1 In-House Pipeline Products -- 9.3.2 Co-Development -- 9.4 Regulatory Strategy -- 9.5 Partnering and Growing -- 9.6 Business Model and Strategy -- 9.6.1 Closing Remarks -- References -- 10 Clinical Benefits of 3D Printing in Healthcare -- 10.1 Introduction -- 10.2 3D Printing Technologies -- 10.2.1 Binder Jetting -- 10.2.2 Vat Photopolymerization -- 10.2.3 Powder Bed Fusion -- 10.2.4 Material Jetting -- 10.2.5 Material Extrusion -- 10.2.5.1 Fused Deposition Modelling -- 10.2.5.2 Semi-Solid Extrusion -- 10.2.5.3 Direct Powder Extrusion -- 10.3 Preclinical Applications of 3D Printing.
10.3.1 Immediate and Modified Release Oral Printlets -- 10.3.2 3D-Printed Drug Delivery Devices for Other Routes of Administration -- 10.4 Clinical Applications of 3D Printing -- 10.4.1 Personalised Medications -- 10.4.2 Improved Acceptability and Medication Compliance -- 10.4.2.1 Paediatric Patients -- 10.4.2.2 Adult and Geriatric Patients -- 10.4.3 Mass Manufacturing -- 10.4.4 Decentralised On-Demand Fabrication -- 10.4.5 Veterinary Applications -- 10.5 Challenges, Regulatory View and Future Applications -- 10.6 Conclusion -- References -- 11 Regulatory Aspects of 3D-Printed Medicinal Products -- 11.1 Introduction -- 11.2 Current Regulatory Framework -- 11.3 Quality Aspects of 3D-Printed Medicinal Products -- 11.4 3D-Printed Paediatric Medicinal Products -- 11.5 3D-Printed Systems With Tailored Release Profiles -- 11.6 Conclusions -- Disclaimer -- References -- Index -- EULA.
Record Nr. UNINA-9910876527503321
Lamprou Dimitrios A.  
Newark : , : John Wiley & Sons, Incorporated, , 2024
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
4d printing 1 : between disruptive research and industrial applications / / Frédéric Demoly, Jean-Claude André
4d printing 1 : between disruptive research and industrial applications / / Frédéric Demoly, Jean-Claude André
Autore Demoly Frédéric
Pubbl/distr/stampa Hoboken, New Jersey : , : John Wiley & Sons, Incorporated, , [2022]
Descrizione fisica 1 online resource (367 pages)
Disciplina 514.742
Collana Systems and industrial engineering series
Soggetto topico Additive manufacturing
Three-dimensional printing
ISBN 1-394-16378-9
1-394-16376-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Half-Title Page -- Title Page -- Copyright Page -- Contents -- Foreword -- Preface -- Preamble: 4D Printing, Between the Why(s) and the How(s) -- P.1. Introduction -- P.2. Toward a more "total" integration of autonomy and matter -- P.3. From research to product(s) -- P.4. References -- Introduction -- I.1. Attempt to define 3D printing -- I.2. What about 4D printing? -- I.3. An "explosion" of complexities in 4D printing -- I.3.1. Stimulation process -- I.3.2. Materials -- I.3.3. Controlling deformations -- I.4. Conclusion -- I.5. References -- Chapter 1. Is 4D Printing Disruptive or Incremental, or a Bit of Both? -- 1.1. Introduction -- 1.2. Prospective approach -- 1.3. A tectonics of paradigms -- 1.3.1. 3D printing -- 1.3.2. 4D printing -- 1.3.3. The potential development of 4D innovations -- 1.3.4. Note: example of 4D printing in structural electronics (SE) -- 1.3.5. Partial conclusion -- 1.4. 4D printing: breakthrough or increment? -- 1.4.1. Creativity and 4D printing -- 1.4.2. Getting out of blindly following? Where to go? -- 1.4.3. Application to additive manufacturing -- 1.4.4. Application to 4D printing -- 1.5. Financial and organizational aspects -- 1.5.1. Research funding and direction -- 1.5.2. Constraints/opportunities related to research orientation -- 1.6. A hopeful conclusion within an organization that learns -- 1.6.1. General framework -- 1.6.2. Organizing research in 4D printing -- 1.7. Appendix 1: Processing an external file -- 1.8. Appendix 2: Going a step further (working document) -- 1.8.1. Can we break the deadlock? -- 1.8.2. So what? -- 1.9. References -- Chapter 2. Is There External Creativity to Support 4D Printing? -- 2.1. Introduction -- 2.2. A survey for the general public -- 2.2.1. The survey -- 2.2.2. Items not transmitted -- 2.2.3. Some general survey results -- 2.2.4. Note: English language survey.
2.3. Results of the survey -- 2.3.1. Specific ideas and proposals (open questions) -- 2.3.2. Presentation and analysis of the quantified results of the survey -- 2.4. Discussion -- 2.4.1. Non-response (voluntary) -- 2.4.2. Survey responses -- 2.5. Conclusion -- 2.6. Appendix 1: The blank survey -- 2.6.1 What is 4D printing? -- 2.7. Appendix 2: Answers as of February 16, 2021 -- 2.8. References of scientific articles with "4D printing" or "applications" in their titles -- 2.9. References -- 3. Who Would Prevail Today from Lamarck or Darwin to Help the Controlled Evolution of 4D Printing? -- Preamble -- 3.1. Introduction -- 3.2. General considerations -- 3.2.1. The 4D fabrications concerned by this chapter -- 3.2.2. Toward a transposition between theories of nature and 4D printing -- 3.3. General considerations -- 3.3.1. The question of arrangements and the control of the arrow of time -- 3.3.2. Complexity induced by the stimulation -- 3.3.3. Toward a principle of parsimony? -- 3.3.4. To go a little further -- 3.3.5. A partial fallback situation -- 3.3.6. The reverse problem -- 3.4. A view from thermodynamics -- 3.5. Darwin, Lamarck and others… -- 3.5.1. Between Lamarck and Darwin -- 3.5.2. Evolutions -- 3.5.3. Notion of morphogenetic field -- 3.5.3.1. General considerations -- 3.5.3.2. From a more practical point of view -- 3.5.3.3. 4D printing? -- 3.6. Conclusion -- 3.7. References -- Chapter 4. Toward a Possibly Programmable Self-organization? -- 4.1. Introduction -- 4.2. A look at the technology -- 4.3. Natural (spontaneous) self-organization -- 4.3.1. Nonlinearities -- 4.3.2. Achieving the desired shape? -- 4.4. Self-organization and 3D/4D printing -- 4.4.1. General considerations -- 4.4.2. Creation of 3D artifacts -- 4.4.3. What about 4D printing? Stimulated self-organizing systems: bottom-up coupling -- 4.4.3.1. Chemical robots.
4.4.3.2. Some results of stimulated or constrained self-organization -- 4.4.4. Can we envisage a "learning" 4D system? -- 4.4.4.1. Information gathering -- 4.4.4.2. The act of learning -- 4.4.4.2.1. First example -- 4.4.4.2.2. Second example -- 4.4.4.3. Toward an operating manual -- 4.4.5. Removal of a blocking element -- 4.5. Conclusion -- 4.6. References -- Index -- Other titles from iSTE in Systems and Industrial Engineering - Robotics -- EULA.
Record Nr. UNINA-9910829834503321
Demoly Frédéric  
Hoboken, New Jersey : , : John Wiley & Sons, Incorporated, , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
4D Printing, Volume 1 : Between Disruptive Research and Industrial Applications
4D Printing, Volume 1 : Between Disruptive Research and Industrial Applications
Autore Demoly Frederic
Pubbl/distr/stampa Newark : , : John Wiley & Sons, Incorporated, , 2022
Descrizione fisica 1 online resource (367 pages)
Altri autori (Persone) AndreJean-Claude
Soggetto genere / forma Electronic books.
ISBN 1-394-16378-9
1-394-16376-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Half-Title Page -- Title Page -- Copyright Page -- Contents -- Foreword -- Preface -- Preamble: 4D Printing, Between the Why(s) and the How(s) -- P.1. Introduction -- P.2. Toward a more "total" integration of autonomy and matter -- P.3. From research to product(s) -- P.4. References -- Introduction -- I.1. Attempt to define 3D printing -- I.2. What about 4D printing? -- I.3. An "explosion" of complexities in 4D printing -- I.3.1. Stimulation process -- I.3.2. Materials -- I.3.3. Controlling deformations -- I.4. Conclusion -- I.5. References -- Chapter 1. Is 4D Printing Disruptive or Incremental, or a Bit of Both? -- 1.1. Introduction -- 1.2. Prospective approach -- 1.3. A tectonics of paradigms -- 1.3.1. 3D printing -- 1.3.2. 4D printing -- 1.3.3. The potential development of 4D innovations -- 1.3.4. Note: example of 4D printing in structural electronics (SE) -- 1.3.5. Partial conclusion -- 1.4. 4D printing: breakthrough or increment? -- 1.4.1. Creativity and 4D printing -- 1.4.2. Getting out of blindly following? Where to go? -- 1.4.3. Application to additive manufacturing -- 1.4.4. Application to 4D printing -- 1.5. Financial and organizational aspects -- 1.5.1. Research funding and direction -- 1.5.2. Constraints/opportunities related to research orientation -- 1.6. A hopeful conclusion within an organization that learns -- 1.6.1. General framework -- 1.6.2. Organizing research in 4D printing -- 1.7. Appendix 1: Processing an external file -- 1.8. Appendix 2: Going a step further (working document) -- 1.8.1. Can we break the deadlock? -- 1.8.2. So what? -- 1.9. References -- Chapter 2. Is There External Creativity to Support 4D Printing? -- 2.1. Introduction -- 2.2. A survey for the general public -- 2.2.1. The survey -- 2.2.2. Items not transmitted -- 2.2.3. Some general survey results -- 2.2.4. Note: English language survey.
2.3. Results of the survey -- 2.3.1. Specific ideas and proposals (open questions) -- 2.3.2. Presentation and analysis of the quantified results of the survey -- 2.4. Discussion -- 2.4.1. Non-response (voluntary) -- 2.4.2. Survey responses -- 2.5. Conclusion -- 2.6. Appendix 1: The blank survey -- 2.6.1 What is 4D printing? -- 2.7. Appendix 2: Answers as of February 16, 2021 -- 2.8. References of scientific articles with "4D printing" or "applications" in their titles -- 2.9. References -- 3. Who Would Prevail Today from Lamarck or Darwin to Help the Controlled Evolution of 4D Printing? -- Preamble -- 3.1. Introduction -- 3.2. General considerations -- 3.2.1. The 4D fabrications concerned by this chapter -- 3.2.2. Toward a transposition between theories of nature and 4D printing -- 3.3. General considerations -- 3.3.1. The question of arrangements and the control of the arrow of time -- 3.3.2. Complexity induced by the stimulation -- 3.3.3. Toward a principle of parsimony? -- 3.3.4. To go a little further -- 3.3.5. A partial fallback situation -- 3.3.6. The reverse problem -- 3.4. A view from thermodynamics -- 3.5. Darwin, Lamarck and others… -- 3.5.1. Between Lamarck and Darwin -- 3.5.2. Evolutions -- 3.5.3. Notion of morphogenetic field -- 3.5.3.1. General considerations -- 3.5.3.2. From a more practical point of view -- 3.5.3.3. 4D printing? -- 3.6. Conclusion -- 3.7. References -- Chapter 4. Toward a Possibly Programmable Self-organization? -- 4.1. Introduction -- 4.2. A look at the technology -- 4.3. Natural (spontaneous) self-organization -- 4.3.1. Nonlinearities -- 4.3.2. Achieving the desired shape? -- 4.4. Self-organization and 3D/4D printing -- 4.4.1. General considerations -- 4.4.2. Creation of 3D artifacts -- 4.4.3. What about 4D printing? Stimulated self-organizing systems: bottom-up coupling -- 4.4.3.1. Chemical robots.
4.4.3.2. Some results of stimulated or constrained self-organization -- 4.4.4. Can we envisage a "learning" 4D system? -- 4.4.4.1. Information gathering -- 4.4.4.2. The act of learning -- 4.4.4.2.1. First example -- 4.4.4.2.2. Second example -- 4.4.4.3. Toward an operating manual -- 4.4.5. Removal of a blocking element -- 4.5. Conclusion -- 4.6. References -- Index -- Other titles from iSTE in Systems and Industrial Engineering - Robotics -- EULA.
Record Nr. UNINA-9910590098403321
Demoly Frederic  
Newark : , : John Wiley & Sons, Incorporated, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui

Formato

Livello bibliografico

Autore (Persona)

Altro...

Autore (Ente)

Autore (Convegno)

Opere

Altro...

Pubbl/distr/stampa

Altro...

Lingua di pubblicazione

Data

Data di pubblicazione

Altro...

Soggetto (Persona)

Soggetto (Ente)

Soggetto (Convegno)

Soggetto geografico

Altro...

Soggetto topico

Altro...

Soggetto genere / forma

Altro...